<DOC>
	<DOCNO>NCT01704599</DOCNO>
	<brief_summary>Vitamins modulate homocysteine affect TNF-alpha , vascular endothelial growth factor , theoretically enhance anti-inflammatory version NOS thus hopefully increase efficacy reduce chance toxicity adalimumab determine blood test EKGs .</brief_summary>
	<brief_title>Addition Modulators Homocysteine Adalimumab Therapy Treatment Moderate Severe Plaque Psoriasis</brief_title>
	<detailed_description>This pilot study design evaluate whether addition oral vitamin B12 , vitamin B6 , folic acid use adalimumab psoriasis lead improvement patient 's psoriasis quality life .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>adult 18 old moderate severe plaque psoriasis ( &gt; 10 % BSA ) Negative pregnancy test within 7 day first dose adalimumab woman ( except surgically sterile 5 year postmenopausal ) subject must sign/date appropriate write informed consent &amp; HIPAA authorization Sexually active subject childbearing potential must agree use medically acceptable contraception screen throughout study evidence active latent tuberculosis base negative PPD skin test perform screening , within one year start study . Patients documentation adequately treat TB may enrol Patients PPD positive CXR negative enrol finish appropriate INH prophylaxis prior enrollment willing able selfadminister subcutaneous injection qualify person available administer injection agree comply protocol requirement , attend regularly study visit consider good study subject meet concomitant medication washout requirement willing use allow psoriasis medication treatment agree start topical , systemic , phototherapy psoriasis study period adalimumab na√Øve erythrodermic , pustular , guttate psoriasis skin condition psoriasis would interfere studyrelated psoriasis evaluation know sensitivity component study medication Evidence active infection fever , chill , sweat , history untreated Lyme disease active severe infection within 4 week screen visit , screen Week 0 visit history listeriosis , untreated TB , persistent active infection require hospitalization treatment IV antibiotic , IV antiretrovirals , IV antifungal within 30 day baseline , OR oral antibiotic , antiviral , antifungal purpose treat infection , within 14 day baseline positive PPD positive chest xray latent active tuberculosis positive PPD negative chest xray complete appropriate INH prophylaxis On immune compromise drug history immune compromise disorder immunodeficiency poorly control medical condition include , limited , unstable cardiovascular disease , poorly control diabetes , recent stroke , history recurrent infection , condition , opinion investigator , participation study would place subject risk hx . congestive heart failure hx . demyelinate CNS disease History malignancy ( previously treat localized carcinoma situ cervix previously treat nonmelanoma skin cancer ) history ongoing drug alcohol abuse past present psychiatric morbidity may compromise study Pregnant woman , nurse mother , plan become pregnant study within 150 day last dose study medication . Males plan pregnancy spouse/partner study exclude plan receive live vaccine study history liver disease Current enrollment another clinical study/treatment experimental drug approve therapy experimental use within 30 day prior Week 0 previous enrollment study commit assessment require protocol disorder compromise subject give write informed consent and/or comply study procedure consider investigator unsuitable candidate comply protocol washout requirement folic acid dos minimal daily requirement vitamins high minimal daily requirement ( multivitamin allow ) colon polyp cancer prior adalimumab therapy screen plasma Vascular Endothelial Growth Factor level 140 pg/ml</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>B vitamin</keyword>
	<keyword>Homocysteine</keyword>
	<keyword>Folic acid</keyword>
	<keyword>Cyanocobalamin</keyword>
	<keyword>Pyridoxine</keyword>
	<keyword>Vitamin B6</keyword>
	<keyword>Vitamin B9</keyword>
	<keyword>Vitamin B12</keyword>
</DOC>